Safety of S1P Modulators in Patients with Immune-Mediated Diseases: A Systematic Review and Meta-Analysis
Juan S. Lasa, Pablo A. Olivera, Stefanos Bonovas, Silvio Danese, Laurent Peyrin‐Biroulet
Topics & Concepts
MedicineAdverse effectPlaceboInternal medicineRandomized controlled trialMeta-analysisClinical endpointFingolimodImmunologyMultiple sclerosisPathologyAlternative medicineSphingolipid Metabolism and SignalingMultiple Sclerosis Research StudiesPsoriasis: Treatment and Pathogenesis